Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/6/2023
CDE Solicits Comments on Draft Implementation Proposal and Chinese Tra...
1/6/2023
CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11
1/6/2023
China Issues Two New Policies on BMI Reimbursement of Covid Hospitaliz...
1/6/2023
Latest Cancer Drugmaker's IPO Mints China's Latest Billionaire
1/6/2023
Recent Executive Moves
1/6/2023
Drug R&D and Product Registration News Digest January 2023 (1)
1/5/2023
GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...
1/5/2023
CANbridge Consolidates Gene Therapy Portfolio by Exercising License Op...
1/5/2023
NMPA Holds National Drug Regulatory Conference in Beijing
1/5/2023
2022 NRDL Access Negotiation Reinitiated with Industry Hoping for "Mod...
1/5/2023
Adcendo ApS Announces License Agreement with Duality Biologics on Next...
1/5/2023
Aurisco to Build Oligonucleotides Manufacturing Facility in China
1/5/2023
Shionogi Covid Drug Xocova May Get Chinese Approval in March
1/5/2023
20 Promising New Drugs Anticipated To Be Approved in China 2023 (Pharm...
1/5/2023
FDA's Wang Yaning: Anti-Aβ Therapies Can Delay Progression of AD (Pha...
1/4/2023
Biocytogen and Hansoh Pharma Enter Antibody License Deal for China
1/4/2023
NHC and SATCM Announce Action Plan for the Overall Pain Management Tri...
1/3/2023
Fosun Pharma and Henlius Entered into an Exclusive License Agreement f...
1/3/2023
CDE Solicits Comments on the Technical Guidelines for R&D of Oral Comp...
1/3/2023
China Turns Down EU Offer of Free COVID Vaccines
1/3/2023
Legend Biotech's NDA for Ciltacabtagene Autoleucel (Cilta-Cel) Accepte...
12/30/2022
Merck's COVID Drug Molnupiravir Conditionally Approved in China
12/30/2022
CDE Publicizes the List of Reference Formulations for GQCE Studies (65...
12/30/2022
NHC Issues the Clinical Guidelines for New Antitumor Drugs (2022 Editi...
12/30/2022
CNIPA and NHSA Issues Joint Policy on Strengthening IP Protection in C...
12/30/2022
Abbott to Exit China's Pediatric Nutrition Market
12/30/2022
Drug R&D and Product Registration News Digest December 2022 (4)
12/30/2022
Recent Executive Moves
12/30/2022
Financial-related Company News Digest (December 2022)
12/30/2022
Covid Policy U-Turn Puts China in Disarray with Pharma in the Front Ro...
Page:
60
/
719
Total number of articles:
21546
:
[First]
[<<]
[58]
[59]
[60]
[61]
[62]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit